Form 8-K - Current report:
SEC Accession No. 0001213900-25-037115
Filing Date
2025-04-30
Accepted
2025-04-30 08:30:24
Documents
17
Period of Report
2025-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239844-8k_180life.htm   iXBRL 8-K 40214
2 SETTLEMENT AND MUTUAL RELEASE AGREEMENT DATED AND EFFECTIVE APRIL 28, 2025, IS B ea023984401ex10-1_180life.htm EX-10.1 79551
3 VOTING AGREEMENT DATED APRIL 28, 2025, BETWEEN 180 LIFE SCIENCES CORP., ELRAY RE ea023984401ex10-2_180life.htm EX-10.2 30833
4 PRESS RELEASE DATED APRIL 30, 2025 ea023984401ex99-1_180life.htm EX-99.1 17477
  Complete submission text file 0001213900-25-037115.txt   424235

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20250428.xsd EX-101.SCH 3786
6 XBRL DEFINITION FILE atnf-20250428_def.xml EX-101.DEF 26628
7 XBRL LABEL FILE atnf-20250428_lab.xml EX-101.LAB 36679
8 XBRL PRESENTATION FILE atnf-20250428_pre.xml EX-101.PRE 25252
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0239844-8k_180life_htm.xml XML 5822
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 25891161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)